231 related articles for article (PubMed ID: 17057028)
1. The epidemiology of second primary cancers.
Travis LB
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2020-6. PubMed ID: 17057028
[TBL] [Abstract][Full Text] [Related]
2. Second malignant neoplasms: assessment and strategies for risk reduction.
Wood ME; Vogel V; Ng A; Foxhall L; Goodwin P; Travis LB
J Clin Oncol; 2012 Oct; 30(30):3734-45. PubMed ID: 23008293
[TBL] [Abstract][Full Text] [Related]
3. Subsequent malignant neoplasms in cancer survivors.
Ng AK; Travis LB
Cancer J; 2008; 14(6):429-34. PubMed ID: 19060610
[TBL] [Abstract][Full Text] [Related]
4. Second primary cancers: an overview.
Ng AK; Travis LB
Hematol Oncol Clin North Am; 2008 Apr; 22(2):271-89, vii. PubMed ID: 18395150
[TBL] [Abstract][Full Text] [Related]
5. Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations.
Travis LB; Rabkin CS; Brown LM; Allan JM; Alter BP; Ambrosone CB; Begg CB; Caporaso N; Chanock S; DeMichele A; Figg WD; Gospodarowicz MK; Hall EJ; Hisada M; Inskip P; Kleinerman R; Little JB; Malkin D; Ng AK; Offit K; Pui CH; Robison LL; Rothman N; Shields PG; Strong L; Taniguchi T; Tucker MA; Greene MH
J Natl Cancer Inst; 2006 Jan; 98(1):15-25. PubMed ID: 16391368
[TBL] [Abstract][Full Text] [Related]
6. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.
Chaturvedi AK; Engels EA; Gilbert ES; Chen BE; Storm H; Lynch CF; Hall P; Langmark F; Pukkala E; Kaijser M; Andersson M; Fosså SD; Joensuu H; Boice JD; Kleinerman RA; Travis LB
J Natl Cancer Inst; 2007 Nov; 99(21):1634-43. PubMed ID: 17971527
[TBL] [Abstract][Full Text] [Related]
7. An analysis of SEER data of increasing risk of secondary malignant neoplasms among long-term survivors of childhood brain tumors.
Peterson KM; Shao C; McCarter R; MacDonald TJ; Byrne J
Pediatr Blood Cancer; 2006 Jul; 47(1):83-8. PubMed ID: 16317732
[TBL] [Abstract][Full Text] [Related]
8. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
Travis LB; Fosså SD; Schonfeld SJ; McMaster ML; Lynch CF; Storm H; Hall P; Holowaty E; Andersen A; Pukkala E; Andersson M; Kaijser M; Gospodarowicz M; Joensuu T; Cohen RJ; Boice JD; Dores GM; Gilbert ES
J Natl Cancer Inst; 2005 Sep; 97(18):1354-65. PubMed ID: 16174857
[TBL] [Abstract][Full Text] [Related]
9. Therapy-associated solid tumors.
Travis LB
Acta Oncol; 2002; 41(4):323-33. PubMed ID: 12234023
[TBL] [Abstract][Full Text] [Related]
10. Surveillance and monitoring of adult cancer survivors.
Choi M; Craft B; Geraci SA
Am J Med; 2011 Jul; 124(7):598-601. PubMed ID: 21683826
[TBL] [Abstract][Full Text] [Related]
11. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
12. [Second primary malignancy among cancer survivors - epidemiology, prognosis and clinical relevance].
Grundmann RT; Meyer F
Zentralbl Chir; 2012 Dec; 137(6):565-74. PubMed ID: 22426967
[TBL] [Abstract][Full Text] [Related]
13. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors.
Balamurugan A; Ahmed F; Saraiya M; Kosary C; Schwenn M; Cokkinides V; Flowers L; Pollack LA
Cancer; 2008 Nov; 113(10 Suppl):2919-25. PubMed ID: 18980275
[TBL] [Abstract][Full Text] [Related]
14. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.
Brown AP; Chen J; Hitchcock YJ; Szabo A; Shrieve DC; Tward JD
J Clin Endocrinol Metab; 2008 Feb; 93(2):504-15. PubMed ID: 18029468
[TBL] [Abstract][Full Text] [Related]
15. Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea.
Cho YY; Lim J; Oh CM; Ryu J; Jung KW; Chung JH; Won YJ; Kim SW
Cancer; 2015 Jan; 121(2):259-68. PubMed ID: 25223713
[TBL] [Abstract][Full Text] [Related]
16. Late effects of early childhood cancer therapy.
Meadows AT; Gallagher JA; Bunin GR
Br J Cancer Suppl; 1992 Aug; 18():S92-5. PubMed ID: 1503934
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of chronic lymphocytic leukaemia among cancer survivors in the Netherlands: increased detection, causal factors or both?
van den Broek EC; Liu L; Posthuma EF; Janssen-Heijnen ML; Coebergh JW; Soerjomataram I
Ann Hematol; 2014 Jan; 93(1):157-62. PubMed ID: 24381068
[TBL] [Abstract][Full Text] [Related]
18. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
[TBL] [Abstract][Full Text] [Related]
19. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
20. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.
Kleinerman RA; Tucker MA; Abramson DH; Seddon JM; Tarone RE; Fraumeni JF
J Natl Cancer Inst; 2007 Jan; 99(1):24-31. PubMed ID: 17202110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
